--- title: InsightRX to Showcase Precision Dosing Technology at ASHP 2022 Midyear Meeting description: InsightRX provides demonstrations on modules for anticoagulants, azole antifungals, beta-lactams, and solid organ transplant drugs at ASHP 2022. image: https://blog.insight-rx.com/hubfs/InsightRx_ASHP-Image-Mobile-1-1.png --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/) - For Providers - Solutions - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd) - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future) - Products - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova) - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo) - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules) - [For Life Sciences](https://www.insight-rx.com/life-sciences) - Overview - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences) - Products - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova) - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra) - Platform - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning) - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support) - Resources - Science - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science) - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications) - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova) - Explore - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories) - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers) - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software) - [Blog](https://blog.insight-rx.com/resources) - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources) - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership) - Company - About - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about) - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership) - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board) - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers) - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers) - Press - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases) - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) Press Releases # InsightRX to Showcase Precision Dosing Technology at ASHP 2022 Midyear Meeting - Published December 1, 2022 By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx) ![](https://blog.insight-rx.com/hubfs/InsightRx_ASHP-Image-Mobile-1-1.png) SAN FRANCISCO, Dec. 1, 2022 – Today, InsightRX — which provides cloud-based precision dosing support to guide treatment decisions – announced its slate of activities and demonstrations during the American Society of Health-System Pharmacists (ASHP) [2022 Midyear Clinical Meeting and Exhibition](https://midyear.ashp.org/) in Las Vegas from Dec. 4-8. InsightRX supports a patented, data-driven cycle of performance improvement for medication management.  Its trifecta of dosing decision support (Nova), real-time analytics (Apollo) and continuous learning allows for the refinement of existing pharmacokinetic/pharmacodynamic (PK/PD) models and enables the practice of MIPD to ultimately improve drug efficacy, patient safety and reduce unnecessary costs.  At ASHP Midyear, held at the Mandalay Bay Convention Center, they will be showcasing several new therapeutic categories that are now a part of their offering. 2020 brought the [newest vancomycin consensus guidelines](https://academic.oup.com/ajhp/article/77/11/835/5810200), which firmly recommended Bayesian forecasting software as the preferred method of dosing and monitoring.  MIPD with MAP-Bayesian forecasting (MAPB) uses PK/PD models to individualize initial dosing to each patient, and subsequently balances data from those models with measured, patient-specific values to further individualize predictions. Though MIPD/MAPB remains the preferred methodology for dosing and monitoring of vancomycin, expansion of this methodology for additional drugs and therapeutic areas could be vital to ensuring therapeutic success with those agents. As we near the end of 2022, InsightRX looks to the future of therapeutic drug monitoring in an ever-expanding variety of therapeutic areas: Anticoagulants – Appropriate anticoagulation management can help to prevent recurrent embolic events and bleeding events.  Current literature suggests that attaining anticoagulation therapeutic targets quickly is associated with lower in-hospital mortality and lower 30-day mortality.1 Yet, attaining and maintaining therapeutic anticoagulation remains a challenge for pharmacists and other clinicians. Antifungals – Proper dosing of antifungals, such as voriconazole, is essential to patient outcomes. Patients with therapeutic voriconazole concentrations are twice as likely to have a successful outcome compared to those with subtherapeutic concentrations. Also, in a direct head-to-head comparison, 85.7% of voriconazole patients dosed with MIPD/MAPB software reached the therapeutic target with initial dosing, versus 54% when using standard dosing.2 Beta-lactams – Correctly dosing beta-lactam antibiotics to avoid treatment failures and toxicity can significantly improve patient outcomes. However, standard beta-lactam dosing is suboptimal in close to half of all patients, which can lead to worse clinical outcomes and a need for further individualization in our dosing strategy.3-6 Solid organ transplant – Tacrolimus is used with other medications to prevent rejection of a transplanted organ. Inadequate tacrolimus exposure can have grave consequences for patients, increasing their risk of nephrotoxicity and infection risk from overexposure and nearly doubling the risk of organ rejection with underexposure. MIPD/MAPB, using a patient’s specific pharmacokinetics and pharmacogenomics to individualize dosing, has been proven to improve tacrolimus target attainment.7 MIPD software also allows for direct estimation of tacrolimus AUC, eliminating the ambiguity associated with trough-based dosing. > “Advances in therapeutic drug monitoring are transforming the ability of clinicians to give the right dose to a patient quickly and efficiently to drive improved outcomes,” said Sirj Goswami, PhD, CEO and co-founder of InsightRX. “We will continue to expand and add modules that will allow our precision dosing platform to be used for new medications and therapeutic areas.” > “We’re excited to talk at ASHP about our modules: antifungals, beta-lactams, anticoagulants, and solid-organ transplant,” said Jon Faldasz, PharmD, BCPS, and Senior Director Product and Customer Experience for InsightRX. “The combination of model-informed precision dosing and MAP-Bayesian forecasting is enabling us to help increase patient safety and drive clinical innovation.” Stop by InsightRX’s booth (#813) to learn more about how Bayesian model dosing is helping to improve patient care. --- 1. Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Chest 2010;137(6):1382-90 2. Hope W, Johnstone G, Cicconi S,  et al. Antimicrob Agents Chemother. 2019;63(4):e02353-18 3. 3. Kunz Coyne AJ, Alshaer M, Casapao AM, et al. Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0064622. 4. Carrie C, Petit L, d’Houdain N, et al. Int J Antimicrob Agents. 2018 Mar;51(3):443-449. 5. Carrie C, Chadefaux G, Sauvage N, et al. Crit Care. 2019 Nov 27;23(1):379. 6. Abdulla A, Dijkstra A, Hunfeld NGM, et al. Crit Care. 2020 Sep 15;24(1):558. 7. Marquet P, Cros F, Micallef L, et al. Ther Drug Monit. 2021;43(4):472-480 [antifungals](https://blog.insight-rx.com/press-releases/tag/antifungals) [transplant](https://blog.insight-rx.com/press-releases/tag/transplant) [conferences](https://blog.insight-rx.com/press-releases/tag/conferences) [ASHP](https://blog.insight-rx.com/press-releases/tag/ashp) [beta-lactams](https://blog.insight-rx.com/press-releases/tag/beta-lactams) [anticoagulation](https://blog.insight-rx.com/press-releases/tag/anticoagulation) #### On this page… **Connect with us to get the latest blog updates, instantly sent to your inbox** ## Dig deeper. Explore related articles and additional posts on the InsightRX blog. [Press Releases Jun 2, 2022 InsightRX Helps Boone County Hospital Improve Patient Safety with Precision Dosing](https://blog.insight-rx.com/press-releases/boone-county-hospital-improve-patient-safety-precision-dosing) [Press Releases Jun 8, 2021 InsightRX’s Precision Medicine Platform Integrated Into Sentara Healthcare EHR To Help Safely Administer Vancomycin Doses For Treatment Of Infections](https://blog.insight-rx.com/press-releases/precision-medicine-platform-integrated-sentara-healthcare-ehr-safely-administer-vancomycin-doses) [Press Releases Oct 11, 2022 InsightRX Offers Precision Dosing Support for New Drug Categories](https://blog.insight-rx.com/press-releases/insightrx-offers-precision-dosing-support-new-drug-categories) #### What We Do ##### For Providers - [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova) - [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo) - [Drug Modules](https://www.insight-rx.com/provider/drug-modules) ##### For Life Sciences - [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova) - [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra) - [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications) #### How We Do It ##### Platform - [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning) - [Integrations](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support](https://www.insight-rx.com/platform/success-support) ##### Science - [Data Science](https://www.insight-rx.com/data-science) - [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications) #### Information ##### Resources - [Success Stories](https://www.insight-rx.com/success-stories) - [White Papers](https://www.insight-rx.com/white-papers) - [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software) - [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova) ##### Blog - [All Posts](https://blog.insight-rx.com/resources) - [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership) #### About - [Our Story](https://www.insight-rx.com/about) - [Leadership](https://www.insight-rx.com/leadership) - [Advisory Board](https://www.insight-rx.com/advisory-board) - [Our Customers](https://www.insight-rx.com/customers) - [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media](https://blog.insight-rx.com/press-releases?section=media) - [Careers](https://www.insight-rx.com/careers) - [Contact](https://www.insight-rx.com/contact-us) --- ![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg) InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1. InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance. 740-05000-REC-01 · 08/2025 --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/) 548 Market Street #88083 San Francisco, CA 94104 --- © 2026 InsightRX, Inc. All rights reserved. [Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InsightRX Communications", "url" : "https://blog.insight-rx.com/press-releases/author/insightrx" }, "dateModified" : "2025-12-15T00:36:46.552Z", "datePublished" : "2022-12-01T19:38:00.000Z", "headline" : "InsightRX to Showcase Precision Dosing Technology at ASHP 2022 Midyear Meeting", "image" : [ "https://blog.insight-rx.com/hubfs/InsightRx_ASHP-Image-Mobile-1-1.png" ], "mainEntityOfPage" : { "@id" : "https://blog.insight-rx.com/press-releases/insightrx-showcase-precision-dosing-technologyat-ashp-2022-midyear-meeting", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png" }, "name" : "InsightRX" } } ```